老年胰腺癌早期诊断及微创外科治疗的研究进展

doi:10.11904/j.issn.1002-3070.2023.03.010

实用肿瘤学杂志 ›› 2023, Vol. 37 ›› Issue (3): 257-261.doi: 10.11904/j.issn.1002-3070.2023.03.010

老年胰腺癌早期诊断及微创外科治疗的研究进展

徐婷, 程华综述, 张维审校

四川大学华西医院上锦南府医院普外一科(成都 610000)

收稿日期:2023-02-23 修回日期:2023-04-17 出版日期:2023-06-28 发布日期:2023-08-07
通讯作者: 张维,E-mail:85438079@qq.com
作者简介:徐婷,女,(1990-),本科,从事肝胆胰胃肠方向的研究。
基金资助:
四川省科技计划项目(编号:2015SZ0088)

Research progress in the early diagnosis and minimally invasive surgical treatment of elderly pancreatic cancer

XU Ting, CHENG Hua, ZHANG Wei

Department of General Surgery I,Shangjin Nanfu Hospital,West China Hospital,Sichuan University,Chengdu 610000,China

Received:2023-02-23 Revised:2023-04-17 Online:2023-06-28 Published:2023-08-07

摘要/Abstract

摘要： 近年来,胰腺癌的发病率逐渐升高,老年胰腺癌的比重也逐渐上升,因此在临床诊疗工作中,需给予老年胰腺癌诊疗工作更多重视。然而临床实践发现老年胰腺癌诊治工作还存在不足,最为明显的是早期诊断率低,因而患者接受根治术的比例较低,导致临床疗效及预后较差。当前关于胰腺癌的诊断已有多种可行方法,微创外科治疗是胰腺癌临床治疗的重要选择。本文具体论述老年胰腺癌早期诊断及微创外科治疗现状,以期为老年胰腺癌诊疗工作提供一定指导。

关键词: 老年, 胰腺癌, 诊断, 微创外科, 治疗

Abstract: In recent years,the incidence of pancreatic cancer has gradually increased,and the proportion of elderly pancreatic cancer has also gradually increased,Therefore,in clinical diagnosis and treatment,more attention should be paid to the diagnosis and treatment of pancreatic cancer in the elderly.However,clinical practice has found that the diagnosis and treatment of elderly pancreatic cancer is still insufficient,the most obvious is the low rate of early diagnosis,so the proportion of patients receiving radical surgery is low,leading to poor clinical efficacy and prognosis.Currently,there are many feasible methods for the diagnosis of pancreatic cancer,and minimally invasive surgery is an important choice for the clinical treatment of pancreatic cancer.This article discusses the status of early diagnosis and minimally invasive surgical treatment of elderly pancreatic cancer in order to provide a certain guidance for the diagnosis and treatment of pancreatic cancer in the elderly.

Key words: Elderly, Pancreatic cancer, Diagnosis, Minimally invasive surgery, Treatment

中图分类号:

R735.9

徐婷, 程华, 张维. 老年胰腺癌早期诊断及微创外科治疗的研究进展[J]. 实用肿瘤学杂志, 2023, 37(3): 257-261.

XU Ting, CHENG Hua, ZHANG Wei. Research progress in the early diagnosis and minimally invasive surgical treatment of elderly pancreatic cancer[J]. Journal of Practical Oncology, 2023, 37(3): 257-261.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/10.11904/j.issn.1002-3070.2023.03.010

http://journal09.magtechjournal.com/Jwk3_syzlxzz/CN/Y2023/V37/I3/257

参考文献

1 马翼飞,贺海蓉,晏天傲,等.1990—2019年中国、日本、韩国胰腺癌流行病学趋势及主要风险归因分析[J].中华消化外科杂志,2022,21(4):507-519.
2 Cai J,Chen H,Lu M,et al.Advances in the epidemiology of pancreatic cancer:Trends,risk factors,screening,and prognosis[J].Cancer Lett,2021,10(520):1-11.
3 蔡洁,陈宏达,卢明,等.2005-2015年中国胰腺癌发病与死亡趋势分析[J].中华流行病学杂志,2021,42(5):794-800.
4 Kanno A,Masamune A,Hanada K,et al.Multicenter study of early pancreatic cancer in Japan[J].Pancreatology,2018,18(1):61-67.
5 Kanno A,Masamune A,Hanada K,et al.Advances in early detection of pancreatic cancer[J].Diagnostics,2019,9(1):18.
6 吴丽权,郭文,李跃,等.内镜超声引导下细针抽吸术对胰腺导管腺癌的预测及诊断价值[J].南方医科大学学报,2018,38(10):1171-1178.
7 Kuruma S,Kikuyama M,Chiba K,et al.Carcinoma in situ of the pancreas with pancreatic duct stricture persistent for 4 years diagnosed by serial pancreatic juice aspiration cytologic examination(SPACE)[J].Clin J Gastroenterol,2020,13(3):443-447.
8 Ishikawa-Kakiya Y,Maruyama H,Kinoshita Y,et al.The usefulness of serial pancreatic juice aspiration cytological examination for pancreatic cancer not diagnosed by EUS-FNAB[J].Clin J Gastroenterol,2020,13(6):1367-1372.
9 Hanada K,Minami T,Shimizu A,et al.Roles of ERCP in the early diagnosis of pancreatic cancer[J].Diagnostics,2019,9(1):30.
10 Yamashita Y,Kitano M,Ashida R.Value of endoscopy for early diagnosis of pancreatic carcinoma[J].Dig Endosc,2020,32(1):27-36.
11 张灿,孙备.美国国立综合癌症网络临床实践指南:胰腺癌(2022.V1)更新解读[J].临床外科杂志,2023,31(1):7-10.
12 Yeh R,Dercle L,Garg I,et al.The Role of 18F-FDG PET/CT and PET/MRI in pancreatic ductal adenocarcinoma[J].Abdom Radiol,2018,43(2):415-434.
13 吴彪,弓健,程勇,等.对比18F-FDG PET/CT与PET/MRI诊断胰腺占位性病变[J].中国医学影像技术,2021,(11):1614-1618.
14 Liu X,Ren Y,Wang J,et al.The Clinical Diagnostic Value of F-FDG PET/CT Combined with MRI in Pancreatic Cancerp[J].Contrast Media Mol Imaging,2022,2022:1479416.
15 Nakamura S,Sadakari Y,Ohtsuka T,et al.Pancreatic juice exosomal microRNAs as biomarkers for detection of pancreatic ductal adenocarcinoma[J].Ann Surg Oncol,2019,26(7):2104-2111.
16 Tao L,Zhou J,Yuan C,et al.Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer[J].Metabolomics,2019,15(6):86-90.
17 郭怀斌,李凤飞,刘一璠,等.GPC-1外泌体、CD82外泌体和CA19-9用于胰腺癌诊断的病例对照研究[J].河北医科大学学报,2022,43(1):35-38.
18 Zhou Q,Andersson R,Hu D,et al.Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis[J].Transl Res,2019,212(20):67-79.
19 Xu X,Xiao Y,Hong B,et al.Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer[J].Cancer Biomark,2019,25(3):251-257.
20 Xu J,Liao K,Fu Z,et al.A new method for early detection of pancreatic cancer biomarkers:detection of micro RNAs by nanochannels[J].Artif Cells Nanomed Biotechnol,2019,47(1):2634-2640.
21 王勇.CA19-9联合K-ras基因突变检测对胰腺癌的诊断价值[J].西藏医药,2022,43(3):23-25.
22 梅晗,周辉,陈煜枫,等.外周血E-selectin、P-selection及K-ras基因突变水平在胰腺癌中的表达及意义[J].解放军医药杂志,2021,33(1):16-19,26.
23 田永,王瑞勤,常越,等.微小RNA-143、糖类抗原19-9在胰腺癌诊断和预后预测中的应用价值[J].癌症进展,2022,20(14):1505-1508.
24 刘允怡.腔镜下胰十二指肠切除微创手术在胰头癌的应用[J].中华腔镜外科杂志(电子版),2017,10(6):321-323.
25 Chapman BC,Gajdos C,Hosokawa P,et al.Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma[J].Surg Endosc,2018,32(5):2239-2248.
26 成功,阮一,王逻逻,等.高龄腹腔镜胰十二指肠切除术39例临床分析[J].现代实用医学,2022,34(3):296-298.
27 李红霞,东爱华.老年患者腹腔镜胰十二指肠切除术后胰瘘的危险因素分析[J].老年医学与保健,2022,28(3):488-492.
28 刘荣,赵国栋,唐文博,等.机器人胰腺手术 1010 例经验与教训[J].南方医科大学学报,2018,38(2):130-134.
29 Shyr YM,,Wang SE,Chen SC,et al.Robotic pancreaticoduodenectomy for pancreatic head cancer and periampullary lesions[J].Ann Gastroenterol Surg,2021,5(5):589-596.
30 党树伟,刘明,李广恩,等.Da Vinci Xi机器人胰十二指肠切除术(附5例报告)[J].腹腔镜外科杂志,2020,25(6):407-411.
31 Nassour I,Choti MA,Porembka MR,et al.Robotic-assisted versus laparoscopic pancreaticoduodenectomy:Oncological outcomes[J].Surg Endosc,2018,32(6):2907-2913.
32 代鑫,刘汉林,王强,等.达芬奇机器人与传统腹腔镜胰十二指肠切除术近期疗效及安全性比较的Meta分析[J].临床肝胆病杂志,2022,38(5):1106-1113.
33 Gavriilidis P,Roberts KJ,Sutcliffe RP.Laparoscopic versus open distal pancreatectomy for pancreatic adenocarcinoma:a systematic review and Meta-analysis[J].Acta Chir Belg,2018,118(5):278286.
34 Raoof M,Ituarte P,Woo Y,et al.Propensity score-matched comparison of oncological outcomes between laparoscopic and open distal pancreatic resection[J].Br J Surg,2018,105(5):578-586.
35 Larkins K,Rowcroft A,Pandanaboyana S,et al.A systematic scoping review of the initial experience with laparoscopic radical antegrade modular pancreatosplenectomy for pancreatic malignancy[J].Surg Endosc.2021,35(9):4930-4944.
36 Kantor O,Bryan DS,Talamonti MS,et al.Laparoscopic distal pancreatectomy for cancer provides oncologic outcomes and overall survival identical to open distal pancreatectomy[J].J Gastrointest Surg,2017,21(10):1620-1625.

[1]	张庆怀, 韩阿蒙, 杨森, 李秀梅, 赵健鑫, 张彦秋. 乳腺癌患者保乳术后五种放疗技术的疗效比较研究[J]. 实用肿瘤学杂志, 2023, 37(3): 224-229.
[2]	陈琪, 何明旭, 贾科良, 苗健龙, 韩丽萍. TP53-EGFR共突变对非小细胞肺癌预后及治疗的研究进展[J]. 实用肿瘤学杂志, 2023, 37(3): 262-266.
[3]	伦立鑫, 钟振滨, 赵新宇, 吴筹, 郝春成. 抗EGFR治疗在头颈部鳞癌中的研究进展[J]. 实用肿瘤学杂志, 2023, 37(3): 276-280.
[4]	殷鼎威, 井杰. 肠道菌群在肝细胞癌中的作用及治疗应用的研究进展[J]. 实用肿瘤学杂志, 2023, 37(3): 281-286.
[5]	王丙萍, 段金凯, 张双, 高艳伟, 任猛, 陈良全, 高维实. NK细胞联合PD-1单抗杀伤结直肠癌细胞的研究[J]. 实用肿瘤学杂志, 2023, 37(2): 130-136.
[6]	李路桥, 邹征云. 恶性黑色素瘤免疫治疗超进展研究现状[J]. 实用肿瘤学杂志, 2023, 37(2): 144-148.
[7]	文世超, 王静萱. 铜依赖性细胞死亡及铜在乳腺癌治疗中的研究现状[J]. 实用肿瘤学杂志, 2023, 37(2): 185-189.
[8]	王嘉倍, 张运广, 刘连新. 免疫治疗联合分子靶向药物治疗中晚期肝细胞癌的临床疗效及安全性分析:一项单臂回顾性研究[J]. 实用肿瘤学杂志, 2022, 36(6): 489-494.
[9]	杨菊, 刘芹, 刘宝瑞, 魏嘉. 胃癌相关癌睾抗原筛选与免疫浸润分析[J]. 实用肿瘤学杂志, 2022, 36(6): 495-501.
[10]	巩芮宁, 任贺. 胰腺导管腺癌免疫治疗研究现状和展望[J]. 实用肿瘤学杂志, 2022, 36(6): 502-506.
[11]	曹文杰, 魏瑗, 邝栋明. 肿瘤浸润B细胞与免疫治疗[J]. 实用肿瘤学杂志, 2022, 36(6): 507-512.
[12]	张玥, 汪越, 魏嘉. SHP2作为抗肿瘤治疗靶点的价值及其在肿瘤免疫治疗中的应用[J]. 实用肿瘤学杂志, 2022, 36(6): 513-519.
[13]	程思远, 韩子翰, 郭晓欢, 沈琳, 彭智. 肠道菌群与肿瘤免疫治疗疗效及不良反应关系的研究进展[J]. 实用肿瘤学杂志, 2022, 36(6): 520-525.
[14]	孙兴璐, 陈彻. Egr1在肝癌中的研究进展[J]. 实用肿瘤学杂志, 2022, 36(5): 435-439.
[15]	王星涵, 吕雅蕾. 曲妥珠单抗耐药机制及HER2阳性乳腺癌耐药后的治疗策略[J]. 实用肿瘤学杂志, 2022, 36(5): 445-451.

老年胰腺癌早期诊断及微创外科治疗的研究进展

Research progress in the early diagnosis and minimally invasive surgical treatment of elderly pancreatic cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价